New Study Evaluates High Dose Ivermectin, Fluvoxamine, and Metformin for Outpatient COVID-19

Share

MedCram – Medical Lectures Explained CLEARLY

Roger Seheult, MD of MedCram examines a new study comparing high dose Ivermectin, Fluvoxamine, and Metformin for outpatient COVID-19.

See all Dr. Seheult’s videos at: https://www.medcram.com

Roger Seheult, MD is the co-founder and lead professor at https://www.medcram.com He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine.


LINKS / REFERENCES:

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19 (NEJM) | https://www.nejm.org/doi/full/10.1056…

Mission (Parsemus Foundation) | https://www.parsemus.org

Prevention Protocol (FLCCC) | https://covid19criticalcare.com/wp-co…

DISCLAIMER: MedCram medical videos are for medical education and exam preparation, and NOT intended to replace recommendations from your doctor.

#COVID19 #Omicron #Coronavirus